Experience with apremilast in a small cohort of patients with chronic plaque psoriasis

被引：0
|
作者：
Cranwell, W. [1 ]
Radulski, B. [1 ]
Dolianitis, C. [1 ]
Nicolopoulos, J. [1 ]
Varigos, G. A. [1 ]
机构：
[1] Royal Melbourne Hosp, Dermatol Unit, Melbourne, Vic, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Three years' clinical experience with alefacept in 200 patients with chronic plaque psoriasis
    Menter, Alan
    Perlmutter, Amy
    Jaracz, Eileen
    Cather, Jennifer
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB124 - AB124
  • [22] A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
    Srivastava, Divyanshu
    Krishna, Arvind
    David, Abhinav
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (04) : 393 - 398
  • [23] Characteristics of patients newly initiating ustekinumab, adalimumab, secukinumab, apremilast or methotrexate for plaque psoriasis
    Lee, Seina
    Carroll, Charlotte
    Pericone, Christopher
    Tunceli, Ozgur
    Fakharzadeh, Steve
    Feldman, Steve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB66 - AB66
  • [24] Efficacy and safety of apremilast in patients with moderate plaque psoriasis (UNVEIL phase 4 study)
    Strober, Bruce
    Bagel, Jerry
    Lebwohl, J. Mark
    Gold, Linda Stein
    Jackson, J. Mark
    Chen, Rongdean
    Levi, Eugenia
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB111 - AB111
  • [25] Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis
    Sacchelli, L.
    Patrizi, A.
    Loi, C.
    Bardazzi, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) : E243 - E244
  • [26] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
    Ohata, Chika
    Ohyama, Bungo
    Kuwahara, Fumi
    Katayama, Eri
    Nakama, Takekuni
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
  • [27] Characteristics and treatment patterns of plaque psoriasis patients newly initiated on apremilast or etanercept therapy
    Accortt, Neil
    Zaha, Rebecca
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB66 - AB66
  • [28] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S424 - S425
  • [29] Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
    Ohata, Chika
    Ohyama, Bungo
    Kuwahara, Fumi
    Katayama, Eri
    Nakama, Takekuni
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 383 - 386
  • [30] Prolidase activity in chronic plaque psoriasis patients
    Surucu, Hacer Akin
    Aksoy, Nurten
    Ozgoztas, Orhan
    Sezen, Hatice
    Yesilova, Yavuz
    Turan, Enver
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2015, 32 (02): : 82 - 87
12345